Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case–control study

Overview of attention for article published in BMC Gastroenterology, May 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

news: 1 news outlet

twitter: 2 X users

Readers on

mendeley: 6 Mendeley

Summary News X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 2,244 followers.

【症例対照研究】クロピドグレルは大腸癌リスクを減少させたが、アスピリンやクロピドグレル+アスピリンではリスク減少が見られなかった。DOACは大腸癌に影響しなかった。PPIおよびPPI+DOACは大腸癌リスクを増加させたが、PPI+アスピリンはリスクを減少させた。 #ペ読 https://t.co/kds99x1rMq

15 May 2022

Reply Repost Favourite

New article: Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case-control study https://t.co/GVVi0cAhLu #colorectalcancer #oncology https://t.co/hJJaT4Y0ec

10 May 2022

Reply Repost Favourite

New article: Anticoagulant drugs with or without proton pump inhibitor and colorectal cancer risk: a population-based, case-control study https://t.co/BXkF2BlPOa #livercancer #oncology https://t.co/Xh0C4qfi9f

10 May 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.